Please assess the completion status of the following clinical trial:

Trial Title: Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* We will include pregnant women between 22 0/7 to 31 6/7 weeks gestation who present with regular uterine contractions defined as at least one contraction every 10 minutes for 30 minutes with at least one of the following:~* cervical change of at least 1 cm or~* cervical dilation of 2 cm at the time of initial exam or~* positive fetal fibronectin and transvaginal cervical length \<2.5 cm~Exclusion Criteria:~* We will exclude pregnant women with any contraindication to tocolysis:~* clinical chorioamnionitis (defined as a temperature of \>100.4 F and any of the following: fundal tenderness, maternal tachycardia, fetal tachycardia or purulent vaginal discharge)~* non reassuring fetal heart tones~* suspected placental abruption~* preterm premature rupture of membranes~* prior tocolytic treatment during the past 48 hours~* known adverse effect to indomethacin or nifedipine~* already receiving nifedipine for chronic hypertension

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Nifedipine (Type: ACTIVE_COMPARATOR): Participants will receive nifedipine 10 mg orally every 20 minutes for 3 doses, then nifedipine 10 mg every 6 hours for a total of 48 hours.
- Nifedipine plus Indomethacin (Type: ACTIVE_COMPARATOR): Participants will receive will receive nifedipine 10 mg orally every 20 minutes for 3 doses, then nifedipine 10 mg every 6 hours for a total of 48 hours, as well as indomethacin 100 mg orally, then indomethacin 50 mg orally every 6 hours for a total of 48 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).